INACTIVE/DISSOLVED

Address

MedImmune Ventures Inc
One MedImmune Way
Gaithersburg, MD 20878
United States

Open Map


VCID: 3030
    Profile

    Corporate information

    Investment activity status
    Not investing

    Selected investments

    Country Date Notes
    Coferon Inc
    Develops orally active drugs that act like small drug molecules, can permeate cell membranes, and once inside, can assemble into larger molecules
    United States 1 Jul 2012 Series B
    Catabasis Pharmaceuticals Inc
    United States 1 Apr 2010
    1 Dec 2011
    Series A
    Ambit Biosciences Inc
    A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer.
    United States 10 Jun 2011 Series D
    Rib-X Pharmaceuticals Inc
    United States 1 Jan 2009 N/A
    Virdante Pharmaceuticals Inc
    A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders.
    United States 31 Dec 2008 Series A
    Arginetix Inc
    Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase.
    United States 1 Oct 2008 Seed
    BrainCells Inc
    A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases.
    United States 1 Mar 2008 Series B
    Active
    VaxInnate Inc
    A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases.
    United States 25 Oct 2006 Series C
    Avidia Inc
    United States 1 May 2005 Series B
    Active
    Iomai Corp
    Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants.
    United States 31 Dec 2003 Series C
    Applied Genetic Technologies Corp
    A gene therapy company that designs, packages and delivers therapeutic genes to treat a variety of medical illnesses using the adeno-associates virus.
    United States N/A
    Critical Therapeutics Inc
    Discoverer, developer and commercialize novel therapies.
    United States N/A
    Xencor Inc
    Provider of protein engineering technology platforms in the biotechnology industry.
    United States N/A
    Tercica Inc
    A biopharmaceutical company developing new therapeutics for endocrine system disorders.
    United States N/A
    VLST Corp
    United States N/A
    Vanda Pharmaceuticals Inc
    Biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders.
    United States N/A
    Synovex Corp
    United States N/A
    VaxInnate Corp
    United States N/A
    Corridor Pharmaceuticals Inc
    United States N/A

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.